Opinion
Video
Author(s):
Experts on prostate cancer discuss how treatment has evolved over the years, focusing on doublet and triplet therapy and their utility.
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
Phase 1 study launches for novel CYP11A1 inhibitor for mCRPC
Dr. Murphy on increasing diversity in cancer clinical trials
GLP-1 agonist use is rising in men with prostate cancer
ARANOTE: Darolutamide improves HRQoL in mHSPC